600
Participants
Start Date
December 28, 2017
Primary Completion Date
May 26, 2018
Study Completion Date
December 28, 2018
Three-dose regimen of high dosage investigational sIPV
The investigational vaccines were manufactured by Beijing Minhai Biotechnology Co. Ltd..
Three-dose regimen of medium dosage investigational sIPV
The investigational vaccines were manufactured by Beijing Minhai Biotechnology Co. Ltd..
Three-dose regimen of low dosage investigational sIPV
The investigational vaccines were manufactured by Beijing Minhai Biotechnology Co. Ltd..
Three-dose regimen of commercialized sIPV
The control vaccine was manufactured by Chinese Academy of Medical Sciences.
Three-dose regimen of commercialized IPV
The control vaccine was manufactured by Sanofi Pasteur S.A (IMOVAX POLIO).
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing
Collaborators (1)
Beijing Minhai Biotechnology Co., Ltd
INDUSTRY
Jiangsu Province Centers for Disease Control and Prevention
NETWORK